Pfizer Inc
NYSE:PFE

Watchlist Manager
Pfizer Inc Logo
Pfizer Inc
NYSE:PFE
Watchlist
Price: 25.17 USD -0.04% Market Closed
Market Cap: 143.1B USD

Pfizer Inc
Depreciation & Amortization

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Pfizer Inc
Depreciation & Amortization Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
Pfizer Inc
NYSE:PFE
Depreciation & Amortization
-$5B
CAGR 3-Years
-14%
CAGR 5-Years
-7%
CAGR 10-Years
-3%
Johnson & Johnson
NYSE:JNJ
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bristol-Myers Squibb Co
NYSE:BMY
Depreciation & Amortization
-$4.2B
CAGR 3-Years
24%
CAGR 5-Years
13%
CAGR 10-Years
-45%
Merck & Co Inc
NYSE:MRK
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zoetis Inc
NYSE:ZTS
Depreciation & Amortization
-$131m
CAGR 3-Years
5%
CAGR 5-Years
4%
CAGR 10-Years
-8%
Eli Lilly and Co
NYSE:LLY
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Pfizer Inc
Glance View

Pfizer Inc., a name synonymous with pharmaceutical innovation, embarked on its journey in 1849 when German immigrants Charles Pfizer and Charles Erhart founded the company in Brooklyn, New York. Over the decades, the modest chemical business transformed into a titan of the pharmaceutical industry, delivering breakthroughs that have shaped modern medicine. The company operates through its robust engine of research and development, continually investing billions into discovering and bringing to market medications that address unmet medical needs. Spanning therapeutic areas such as oncology, vaccines, rare diseases, and cardiovascular and metabolic health, Pfizer's strategic focus ensures a diverse product pipeline that aligns with global health trends and challenges. The company's revenue model is predominantly driven by the development, marketing, and sale of its pharmaceutical products. Blockbuster drugs like Lipitor and recently, the COVID-19 vaccine developed in collaboration with BioNTech, have contributed significantly to its earnings. Pfizer's ability to maintain a strong balance between branded pharmaceuticals and generics allows it to effectively cater to both emerging markets and developed economies, while its strategic partnerships and acquisitions further bolster its reach and capabilities. The synergy of science and business acumen at Pfizer has made it not only a hub of medical innovation but also a formidable enterprise in the competitive landscape of healthcare.

PFE Intrinsic Value
27.66 USD
Undervaluation 9%
Intrinsic Value
Price

See Also

What is Pfizer Inc's Depreciation & Amortization?
Depreciation & Amortization
-5B USD

Based on the financial report for Sep 28, 2025, Pfizer Inc's Depreciation & Amortization amounts to -5B USD.

What is Pfizer Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
-3%

Over the last year, the Depreciation & Amortization growth was 4%. The average annual Depreciation & Amortization growth rates for Pfizer Inc have been -14% over the past three years , -7% over the past five years , and -3% over the past ten years .

Back to Top